Myeloid-Derived Suppressor Cells: A Multifaceted Accomplice in Tumor Progression

por Cheng, Jia-Nan, Yuan, Yi-Xiao, Zhu, Bo, Jia, Qingzhu
Publicado 2021

Gene expression profiling identified TP53(Mut)PIK3CA(Wild) as a potential biomarker for patients with triple-negative breast cancer treated with immune checkpoint inhibitors

por Cheng, Jia'Nan, Ding, Xiaofang, Xu, Shouxia, Zhu, Bo, Jia, Qingzhu
Publicado 2020

Chromothripsis is correlated with reduced cytotoxic immune infiltration and diminished responsiveness to checkpoint blockade immunotherapy

por Chu, Han, Jin, Zheng, Cheng, Jia-nan, Jia, Qingzhu, Zhu, Bo, Cai, Haoyang
Publicado 2023

Prognostic and clinical significance of HER-2 low expression in early-stage gastric cancer

por Yang, Tao, Xu, Rui, You, Junhao, Li, Fang, Yan, Bing, Cheng, Jia-nan
Publicado 2022

Association between angiogenesis and cytotoxic signatures in the tumor microenvironment of gastric cancer

por Feng, Yi, Dai, Ying, Gong, Zhihua, Cheng, Jia-Nan, Zhang, Longhui, Sun, Chengdu, Zeng, Xianghua, Jia, Qingzhu, Zhu, Bo
Publicado 2018

Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location

por Zhang, Longhui, Zhao, Yuetao, Dai, Ying, Cheng, Jia-Nan, Gong, Zhihua, Feng, Yi, Sun, Chengdu, Jia, Qingzhu, Zhu, Bo
Publicado 2018

Radiation-induced eosinophils improve cytotoxic T lymphocyte recruitment and response to immunotherapy

por Cheng, Jia-Nan, Luo, Wen, Sun, Chengdu, Jin, Zheng, Zeng, Xianghua, Alexander, Peter B., Gong, Zhihua, Xia, Xin, Ding, Xiaofang, Xu, Shouxia, Zou, Ping, Wan, Yisong Y., Jia, Qingzhu, Li, Qi-Jing, Zhu, Bo
Publicado 2021

Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer

por Jia, Qingzhu, Wu, Wei, Wang, Yuqi, Alexander, Peter B., Sun, Chengdu, Gong, Zhihua, Cheng, Jia-Nan, Sun, Huaibo, Guan, Yanfang, Xia, Xuefeng, Yang, Ling, Yi, Xin, Wan, Yisong Y., Wang, Haidong, He, Ji, Futreal, P. Andrew, Li, Qi-Jing, Zhu, Bo
Publicado 2018

Peripheral eosinophil counts predict efficacy of anti-CD19 CAR-T cell therapy against B-lineage non-Hodgkin lymphoma

por Jia, Qingzhu, Qin, Diyuan, He, Feng, Xie, Qichao, Ying, Zhitao, Zhang, Yajing, Song, Yuqin, Cheng, Jia-Nan, Zuo, Xuejiao, Xu, Luxiang, Fang, Hongliang, Hu, Chunyan, Peng, Lina, Jin, Tao, Shi, Zixiao, Alexander, Peter B., Wang, Yongsheng, Liu, Yarong, Han, Weidong, Zhu, Jun, Wang, Pin, Li, Qi-Jing, Zhu, Bo
Publicado 2021